Management reassured investors that there could be substantial value in its lead drug candidate, VK2735.

The first thing you notice about the Viking 44 Open is her racy, eye-pleasing and proportional profile. From that slightly raked bow to her gently sloping sheer, and the way the wraparound windshield ...

Viking Therapeutics is nearing the finish line with a candidate for weight loss -- to potentially enter a drug market that’s approaching $100 billion. This biotech has candidates in phase 2 and phase ...

Viking (NYSE:VIK) priced its secondary offering of an aggregate of ~30.53M ordinary shares at a public offering price of $44.20 per share. The offering is expected to close on May 29, 2025. The ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about ...

Viking Holdings Ltd. has set terms for its initial public offering, which puts the cruise operator on a heading to be valued at up to $10.8 billion. The Bermuda-based company said 44 million shares ...

(RTTNews) - Viking Holdings Ltd (VIK) announced the pricing of its secondary offering of an aggregate of about 30.53 million ordinary shares at a public offering price of $44.20 per share. The ...

Subscribe to Marlin magazine and get a year of highly collectible, keepsake editions – plus access to the digital edition and archives. Sign up for the free Marlin email newsletter. This year’s ...

A Viking river cruise ship heading north up the Mississippi River can't finish its voyage because of low water levels, according to a statement from the company on Thursday. "Unusually low water ...